Acute Porphyria Drugs

D10AX03 - Azelaic Acid

Possibly porphyrinogenic
PSP

Rationale
Endogenous organic acid with significant systemic exposure in dermal use
Chemical description
Azelaic acid, endogenous antibacterial substance in creme 200 mg mg / g for dermal use twice daily in acne of moderate severity. Less than 5 % is absorbed through the skin. Urinary excretion is stated to be 25 mg/24 h.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes D10A / D10AX or go back.
References
Tradenames

Skinoren Finacea · Zeliderm Finacea · Skinoren Skinoren Skinoren Finacea · Skinoren Finacea · Skinoren Finacea · Skinoren Skinoren · Skinoren Rosacea Rozelaic Finacea Skinoren Skinoren Finacea · Skinoren Finacea · Skinoren Finacea · Skinoren Skinoren Azelex · Finacea · Skinoren Acide azelaique Acido azelaico Azelaic acid
In cooperation with Ipnet
© NAPOS 2025
An unhandled error has occurred. Reload 🗙